High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

NCT00784537 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

520

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma

Interventions

DRUG: ABVD
DRUG: ABVD and Radiotherapy

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]